| Primary |
| Pulmonary Hypertension |
75.0% |
| Pulmonary Arterial Hypertension |
25.0% |
|
| Off Label Use |
50.0% |
| Vomiting |
50.0% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
25.4% |
| Systemic Sclerosis |
13.0% |
| Product Used For Unknown Indication |
10.3% |
| Pulmonary Hypertension |
7.6% |
| Ischaemia |
6.5% |
| Drug Use For Unknown Indication |
5.9% |
| Prophylaxis |
5.4% |
| General Anaesthesia |
4.3% |
| Peripheral Ischaemia |
4.3% |
| Infection |
2.2% |
| Urinary Retention |
2.2% |
| Vasculitis |
2.2% |
| Analgesia |
1.6% |
| Angiopathy |
1.6% |
| Portopulmonary Hypertension |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Alzheimer's Disease |
1.1% |
| Ankylosing Spondylitis |
1.1% |
| Dementia Alzheimer's Type |
1.1% |
| Depression |
1.1% |
|
| Sepsis |
22.2% |
| Syncope |
13.3% |
| Systemic Sclerosis |
11.1% |
| Haemorrhage |
6.7% |
| Death |
4.4% |
| Headache |
4.4% |
| Hepatitis Cholestatic |
4.4% |
| Oxygen Saturation Decreased |
4.4% |
| Vomiting |
4.4% |
| Disease Progression |
2.2% |
| Drug Dose Omission |
2.2% |
| Drug Exposure During Pregnancy |
2.2% |
| Drug Intolerance |
2.2% |
| Infection |
2.2% |
| Jaw Disorder |
2.2% |
| Off Label Use |
2.2% |
| Pain |
2.2% |
| Premature Baby |
2.2% |
| Pulmonary Veno-occlusive Disease |
2.2% |
| Rectal Haemorrhage |
2.2% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
34.6% |
| Pulmonary Hypertension |
13.2% |
| Drug Use For Unknown Indication |
8.2% |
| Rheumatoid Arthritis |
6.0% |
| Systemic Sclerosis |
6.0% |
| Product Used For Unknown Indication |
5.7% |
| Skin Ulcer |
3.1% |
| Osteoporosis |
2.8% |
| Pain |
2.5% |
| Diuretic Therapy |
2.2% |
| Hypertension |
2.2% |
| Arrhythmia |
1.9% |
| Asthma |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Gout |
1.6% |
| Atrial Fibrillation |
1.3% |
| Bronchospasm |
1.3% |
| Prophylaxis Against Diarrhoea |
1.3% |
| Prophylaxis Of Nausea And Vomiting |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
|
| Right Ventricular Failure |
17.3% |
| Death |
10.7% |
| Pleural Effusion |
8.0% |
| Liver Disorder |
6.7% |
| Hyponatraemia |
5.3% |
| Anaemia |
4.0% |
| Arterial Thrombosis Limb |
4.0% |
| Dizziness |
4.0% |
| Pulmonary Hypertension |
4.0% |
| Rash |
4.0% |
| Right Ventricular Hypertrophy |
4.0% |
| Sepsis |
4.0% |
| Sleep Disorder |
4.0% |
| Systemic Sclerosis |
4.0% |
| Abdominal Hernia |
2.7% |
| Cor Pulmonale |
2.7% |
| General Physical Health Deterioration |
2.7% |
| Pneumonia |
2.7% |
| Post Procedural Haemorrhage |
2.7% |
| Pulmonary Oedema |
2.7% |
|
| Interacting |
| Analgesic Therapy |
26.1% |
| Deep Vein Thrombosis |
17.4% |
| Product Used For Unknown Indication |
17.4% |
| Glaucoma |
13.0% |
| Peripheral Ischaemia |
13.0% |
| Pulmonary Embolism |
8.7% |
| Osteoporosis |
4.3% |
|
| International Normalised Ratio Increased |
50.0% |
| Drug Interaction |
25.0% |
| Tremor |
25.0% |
|
